Atlas Trials

A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris

Clinical trial NCT02411955 · COMPLETED

Trial details

NCT number
NCT02411955
Sponsor
Sun Pharmaceutical Industries, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2014-06-01
Primary completion
2015-01-01
Enrollment
1077

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.